SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Naoki233
Lv1
1
30 积分
2021-02-06 加入
最近求助
最近应助
互助留言
[Expert consensus on the management of adverse events of CDK4/6 inhibitors in breast cancer]
1小时前
待确认
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma
27天前
已完结
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
1个月前
已完结
New insights into ErbB3 function and therapeutic targeting in cancer
1个月前
已完结
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
1个月前
已完结
Toward Understanding the Binding Synergy of Trastuzumab and Pertuzumab to Human Epidermal Growth Factor Receptor 2
1个月前
已完结
HER2 in solid tumors: more than 10 years under the microscope; where are we now?
1个月前
已完结
Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study
1个月前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
1个月前
已完结
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
1个月前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论